Future Healthcare Of America (FUTU) Tops Q2 EPS by 163c

Future Healthcare Of America (NASDAQ: FUTU) reported Q2 EPS of HK$18.24, HK$1.63 better than the analyst estimate of HK$16.61. Revenue for the quarter came in at HK$5.31 billion versus the consensus estimate of HK$4.84 billion.

For earnings history and earnings-related data on Future Healthcare Of America (FUTU) click here.

You May Also Be Interested In

• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• JPMorgan Downgrades Supreme Industries (SI:IN) to Neutral
• Goldman Sachs Reiterates Buy Rating on NetEase.com (NTES)